Docoh
Loading...

MDNA Medicenna Therapeutics

64 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
6-K
MDNA Medicenna Therapeutics Corp
18 Jan 22
Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
7:15am
6-K
MDNA Medicenna Therapeutics Corp
5 Jan 22
Medicenna to Participate in Upcoming January Investor Conferences
9:07am
6-K
MDNA Medicenna Therapeutics Corp
22 Dec 21
Current report (foreign)
7:33am
6-K
MDNA Medicenna Therapeutics Corp
17 Dec 21
Medicenna Receives Regulatory Clearance to Expand the Phase 1/2 ABILITY Study of MDNA11 to Canada
8:00am
6-K
MDNA Medicenna Therapeutics Corp
18 Nov 21
Current report (foreign)
7:15am
6-K
MDNA Medicenna Therapeutics Corp
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
MDNA Medicenna Therapeutics Corp
9 Nov 21
Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference
8:23am
6-K
MDNA Medicenna Therapeutics Corp
4 Nov 21
Current report (foreign)
9:00am
6-K
MDNA Medicenna Therapeutics Corp
27 Oct 21
Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States
8:22am
6-K
MDNA Medicenna Therapeutics Corp
7 Oct 21
Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference
9:10am
6-K
MDNA Medicenna Therapeutics Corp
23 Sep 21
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
5:28pm
6-K
MDNA Medicenna Therapeutics Corp
22 Sep 21
Medicenna Presenting at Next-Gen Cytokine Therapeutics Summit
10:29am
6-K
MDNA Medicenna Therapeutics Corp
20 Sep 21
Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 Program
8:16am
6-K
MDNA Medicenna Therapeutics Corp
14 Sep 21
Current report (foreign)
8:32am
6-K
MDNA Medicenna Therapeutics Corp
9 Sep 21
Medicenna Therapeutics to Present at Upcoming September Investor Conferences
9:05am
6-K
MDNA Medicenna Therapeutics Corp
1 Sep 21
Current report (foreign)
8:00am
6-K
MDNA Medicenna Therapeutics Corp
13 Aug 21
Interim condensed consolidated financial statements of
7:10am
6-K
MDNA Medicenna Therapeutics Corp
4 Aug 21
Current report (foreign)
9:20am
6-K
MDNA Medicenna Therapeutics Corp
27 Jul 21
Medicenna Announces That Initiation of MDNA11 Phase 1/2 Study is on Track; Update to be Provided at the PropThink Digital Conference
10:49am
6-K
MDNA Medicenna Therapeutics Corp
14 Jul 21
Current report (foreign)
9:41am